From the People Who (Probably) Gave Us Covid … By Chris Knight (Florida)
This is suspicious … the Wuhan Institute of Virology has assembled a monkeypox virus genome, which would allow the creation of a “contagious pathogen.” The study was published before the monkeypox, monkey business. The strain is “more pathogenic and [have] been reported to infect humans in various parts of the world.” There is no evidence yet of a release by the CCP, but we will see. At present the virus seems to be spreading through the gay community, which seems to bring back the scenarios of HIV from the 1980s. But, if the virus is genetically engineered or modified, we can expect that this will replicate the panic and freak-outs that were seen with Covid. Just to be sure, get your survivalist house in order.
“The Wuhan Institute of Virology assembled a monkeypox virus genome, allowing the virus to be identified through PCR tests, using a method researchers flagged for potentially creating a “contagious pathogen,” The National Pulse can reveal.
The paper, which was authored by nine Wuhan Institute of Virology researchers and published in the lab’s quarterly scientific journal Virologica Sinica, also follows the wide-scale use of Polymerase Chain Reaction (PCR) tests to identify COVID-19-positive individuals.
Researchers appeared to identify a portion of the monkeypox virus genome, enabling PCR tests to identify the virus, in the paper: “Efficient Assembly of a Large Fragment of Monkeypox Virus Genome as a qPCR Template Using Dual-Selection Based Transformation-Associated Recombination.”
Monkey pox viruses – referred to as “MPXVs” in the paper – have strains that are “more pathogenic and [have] been reported to infect humans in various parts of the world.”
“Quantitative polymerase chain reaction (qPCR) is the gold standard for the detection of orthopoxvirus (including MPXV). For pan-orthopoxviruses detection, the E9L (DNA polymerase) gene has been shown to be an excellent target for qPCR assays. For MPXV detection, Li et al. reported that the C3L (complement-binding protein) gene could be used as the qPCR target for the MPXV Congo Basin strain,” explained the paper before noting that China lacked sufficient genetic information on the virus for PCR detection:
“Since MPXV infection has never been associated with an outbreak in China, the viral genomic material required for qPCR detection is unavailable. In this report, we employed dual-selective TAR to assemble a 55-kb MPXV genomic fragment that encompasses E9L and C3L, two valuable qPCR targets for detecting MPXV or other orthopoxviruses.”
“The primary purpose of assembling a fragment of the MPXV genome is to provide a nucleotide template for MPXV detection,” reiterated the study, which relied on the process of transformation-associated recombination (TAR) to isolate a genomic fragment of the monkeypox virus.
“As an efficient tool for assembling large DNA fragments up to 592 kb in length, TAR assembly has become essential for preparing infectious clones of large DNA/RNA viruses,” explained researchers.
The paper acknowledged that TAR “applied in virological research could also raise potential security concerns, especially when the assembled product contains a full set of genetic material that can be recovered into a contagious pathogen.”
“In this study, although a full-length viral genome would be the ideal reference template for detecting MPXV by qPCR, we only sought to assemble a 55-kb viral fragment, less than one-third of the MPXV genome. This assembly product is fail-safe by virtually eliminating any risk of recovering into an infectious virus while providing multiple qPCR targets for detecting MPXV or other Orthopoxviruses,” posited researchers.
The unearthed study follows the Wuhan Institue of Virology conducting similar research into strains of bat coronaviruses that could infect humans while admitting its facilities lacked proper laboratory safety protocols.”
Transformation-associated recombination (TAR) has been widely used to assemble large DNA constructs. One of the significant obstacles hindering assembly efficiency is the presence of error-prone DNA repair pathways in yeast, which results in vector backbone recircularization or illegitimate recombination products. To increase TAR assembly efficiency, we prepared a dual-selective TAR vector, pGFCS, by adding a PADH1-URA3 cassette to a previously described yeast-bacteria shuttle vector, pGF, harboring a PHIS3–HIS3 cassette as a positive selection marker. This new cassette works as a negative selection marker to ensure that yeast harboring a recircularized vector cannot propagate in the presence of 5-fluoroorotic acid. To prevent pGFCS bearing ura3 from recombining with endogenous ura3-52 in the yeast genome, a highly transformable Saccharomyces cerevisiae strain, VL6-48B, was prepared by chromosomal substitution of ura3-52 with a transgene conferring resistance to blasticidin. A 55-kb genomic fragment of monkeypox virus encompassing primary detection targets for quantitative PCR was assembled by TAR using pGFCS in VL6-48B. The pGFCS-mediated TAR assembly showed a zero rate of vector recircularization and an average correct assembly yield of 79% indicating that the dual-selection strategy provides an efficient approach to optimizing TAR assembly.”
“Oh no! Another scary-sounding disease called “monkeypox” is supposedly spreading, which means the powers that be are getting ready to unleash another round of plandemic tyranny that is sure to include yet another magical new “vaccine” delivered at warp speed.
The World Health Organization (WHO), which we know is actively engaged in bioweapons research, launched an emergency meeting in the United Kingdom to discuss the alleged threat of monkeypox. The United Nations arm claims that “cases” of the disease are expected to “double” from nine to 18, requiring intervention.
Authorities are already stockpiling more smallpox vaccines, which they say will treat people who may have already been exposed to monkeypox. The UK government has about 5,000 injections in its existing national stockpile and has ordered another 20,000 as a supplement to that.
According to the “experts,” homosexual and bisexual men are the number-one spreaders of monkeypox, so perhaps there will be a “remedy” released just for them to help stop the spread.
“One potential course of action to be raised will be whether vaccination with the smallpox vaccine made by Bavarian Nordic, known as Jynneos in the U.S. and Imvanex in the UK, should be used for contacts of people known to be infected,” reports the Telegraph.
“The vaccine is only approved in the UK for protection against smallpox – despite the virus being eliminated since 1980 – but can be used ‘off-licence’ to protect against [monkeypox].”
Is monkeypox a gay disease?
Even though ivermectin and hydroxychloroquine (HCQ) were completely off-limits for use against the Wuhan coronavirus (Covid-19) because that would have been off-label, it is apparently just fine to start injecting suspected monkeypox cases with smallpox vaccines.
The “experts” claim that the smallpox jab is the only non-replicating virus in the world for smallpox or monkeypox, reducing a person’s risk of disease by about 85 percent.
“If a person receives the jab within four days of infection, the vaccine can modify the course of the infection and improve their prognosis,” the Telegraph claims.
“There is growing concern over the outbreak, which constitutes at least nine cases in the UK and has been seen in various other nations. Health teams have been deployed worldwide to isolate and contact trace affected people, with gay and bisexual men urged to pay particular attention to any new rashes or lesions on their body, particularly their genitals.”
Of the nine cases of monkeypox that have been identified in the UK so far, six of them occurred in men who have sex with other men. This suggests that monkeypox might be a gay disease.
“We are urging men who are gay and bisexual to be aware of any unusual rashes or lesions and to contact a sexual health service without delay if they have concerns,” announced Dr. Susan Hopkins, the UK Health Security Agency’s (UKHSA) chief medical advisor.
Prof. Kevin Fenton, also of the UKHSA, added that he wants everyone to be “aware of the signs and symptoms, which include rashes around the mouth, as well as around the genital area.”
New cases of monkeypox are also said to be appearing right on schedule in France, Italy, Sweden and Australia, as well as in the United States, Spain, Portugal and Canada.
With the way the media is talking about monkeypox, it would not be any surprise to see this become the new “covid,” replete with mask mandates, social distancing edicts, and eventually jab mandates once another Operation Warp Speed-type vaccine drive is launched as the “cure.””